miR-194 suppresses high glucose-induced progression of non-small cell lung cancer by targeting NFAT5 (154); overexpression of miR-194 in nasopharyngeal carcinoma suppresses cell proliferation, migration, and invasion by targeting MAP3K3 (155); in breast cancer, miR-194-5p promotes cell proliferation, migration, and invasion by targeting SOX17 (156); in prostate cancer, miR-194 is a driver of cancer metastasis promoting migration, invasion, and EMT (157). Here, MAP3K3 is linked to prostate carcinoma.